Freely Filtered, a NephJC Podcast cover image

Freely Filtered 028: Finerenone for diabetic kidney disease

Freely Filtered, a NephJC Podcast

CHAPTER

Egfr

I think if someone were being doubles advocate here, it would be that there's a different outcome that you're comparing to this well. And I'm not arguing to compare. So also in figure one, you have the key secondary composite outcome of death from cardiovascular causes or hospitalization from heart failure. This composite occurred in 13% of patients with finarinone versus 14.8% of patients on placebo,. It also reached statistical significance with a P-value of 0.03. Let's not forget as GFR is falling, your cardiovascular risk is going way up.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner